HomeCision

Cision

Cannabis

High Tide Places 38th on The Globe and Mail’s Fifth-Annual Ranking of Canada’s Top Growing Companies

September 30, 2023

Biotech

Foresee Pharmaceuticals to Present Phase 1/2 Fanconi Anemia Clinical Study Design for its ALDH2 activator FP-045 at the Fanconi Anemia Research Fund 2023 Scientific Symposium

September 30, 2023

Biotech

FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types

September 30, 2023

Biotech

FDA Roundup: September 29, 2023

September 30, 2023

$Syndax to Announce Topline Results from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia and Host an Investor Call on October 2, 2023$

Biotech

Syndax to Announce Topline Results from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia and Host an Investor Call on October 2, 2023

September 30, 2023

Biotech

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

September 30, 2023

Automotive

AMX Sponsors Team Redline to Elevate Global Sim Racing League, Poised for Market Expansion

September 30, 2023

Automotive

Aptiv to Release Third Quarter 2023 Financial Results

September 30, 2023

Automotive

Onewheel Upgrades Rideability and Safety with Firmware Update. New Features: “Custom Shaping 3.0” for GT and “Haptic Buzz”

September 30, 2023

Automotive

The Rise of Advanced Automotive Lighting in Europe and North America: Convenience and Safety Features Provide Key Growth Opportunities

September 30, 2023

« 1 … 1,400 1,401 1,402 1,403 1,404 … 1,686 »

SEARCH FOR AN ARTICLE

Cision

High Tide Places 38th on The Globe and Mail’s Fifth-Annual Ranking of Canada’s Top Growing Companies

Foresee Pharmaceuticals to Present Phase 1/2 Fanconi Anemia Clinical Study Design for its ALDH2 activator FP-045 at the Fanconi Anemia Research Fund 2023 Scientific Symposium

FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types

FDA Roundup: September 29, 2023

Syndax to Announce Topline Results from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia and Host an Investor Call on October 2, 2023

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

AMX Sponsors Team Redline to Elevate Global Sim Racing League, Poised for Market Expansion

Aptiv to Release Third Quarter 2023 Financial Results

Onewheel Upgrades Rideability and Safety with Firmware Update. New Features: “Custom Shaping 3.0” for GT and “Haptic Buzz”

The Rise of Advanced Automotive Lighting in Europe and North America: Convenience and Safety Features Provide Key Growth Opportunities

LATEST NEWS